Baroreflex sensitivity modulates vasodepressor response to nitroprusside.
Baroreflex activity is a determinant of the homeostatic response to alteration in blood pressure. We examined the factors that determine the magnitude of the vasodepressor response to sequential incremental intravenous infusions of sodium nitroprusside (NP), 0.05 to 6.4 micrograms/kg/min, in eight male patients with essential hypertension. Each infusion level was of 10 minutes' duration. Change from control values of mean arterial pressure (delta MAP), heart rate (delta HR) and plasma norepinephrine (delta NE) were obtained at the end of each infusion level. Significant correlations were found between delta MAP vs log dose NP, delta HR vs delta MAP and delta NE vs delta MAP for each patient (p less than 0.05). However, the slopes of these relationships varied widely between subjects and were significantly correlated with the control blood pressure of each patient. In addition, the sympathetic responsiveness, as measured by delta NE vs delta MAP, was inversely correlated with the degree of vasodepressor response seen. Thus, the magnitude of the vasodepressor response was determined by two major factors: 1) the predrug blood pressure, possibly reflecting altered vascular geometry with hypertension; 2) the degree of sympathetic response, which probably acts by mediating the degree of reflex alpha-adrenergic-mediated arteriolar vasoconstriction.
D001794:Blood Pressure; D005292:Ferricyanides / Q000627:therapeutic use*; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008875:Middle Aged; D009599:Nitroprusside / Q000627:therapeutic use*; D009638:Norepinephrine / Q000097:blood; D011311:Pressoreceptors / Q000502:physiology*; D014655:Vascular Resistance / Q000187:drug effects*
D005292:Ferricyanides; D009599:Nitroprusside; D009638:Norepinephrine